Cara Therapeutics (CARA) EPS US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
EPS, rub | ? | 0.18 | -1.74 | -1.55 | -2.19 | -2.19 | -1.74 | ||
Changes by years, y/y, % | -107% | -1 080% | -11% | +41% | 0% | +1.2% |
Cara Therapeutics. EPS, rub
Cara Therapeutics. EPS, changes, %
Cara Therapeutics (CARA) EPS US GAAP (quarter values) |
||||||||
2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
EPS, rub | ? | -0.59 | -0.59 | -0.56 | -0.37 | -0.23 | -1.74 | |
Changes by years, y/y, % | +9% | +9% | +18% | -37% | -56% | |||
Changes by quarters, q/q, % | +15% | 0% | -5% | -35% | -38% |